Skip to Content
Merck

Outcome of a second patch test reading of TRUE Tests® on D6/7.

Contact dermatitis (2013-01-08)
Jakob Torp Madsen, Klaus Ejner Andersen
ABSTRACT

Background. Two readings of patch test reactions are recommended. Objectives. To evaluate the outcome of a second patch test reading of TRUE Test® allergens on D6/7 in relation to negative or doubtful reactions on D3/4. Methods. This was a retrospective investigation of patch test data from January 1992 to October 2011 from consecutive eczema patients tested with the TRUE Test® panels. Results. In the period of nearly 20 years, a total of 9997 patients were tested. The total number of positive reactions to the 29 allergens was 6509; 4.4% were positive on D6/7 and negative on D3/4; and 9.1% were positive on D6/7 after a doubtful (?+) reaction on D3/4. Neomycin was the most frequent allergen giving delayed positive reactions (57%), followed by budesonide (42%) and hydrocortisone-17-butyrate (31%). Conclusion. A total of 4.4% of positive TRUE Test® reactions would be missed, and 9.1% might be missed, if only one reading was performed on D3/4. The results emphasize that many doubtful reactions at D3/4 may develop into positive reactions at a later reading. This may have important implications for evaluation of the clinical relevance of the test result.

MATERIALS
Product Number
Brand
Product Description

Neomycin sulphate, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Neomycin trisulfate salt hydrate, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Neomycin trisulfate salt hydrate, meets USP testing specifications, powder
Sigma-Aldrich
Neomycin trisulfate salt hydrate, suitable for plant cell culture
Sigma-Aldrich
Neomycin trisulfate salt hydrate, powder
Supelco
Neomycin trisulfate salt hydrate, VETRANAL®, analytical standard